PEG-rhG-CSF in Patients With Lymphoma Receiving Chemotherapy
NCT02805218
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
410
Enrollment
INDUSTRY
Sponsor class
Conditions
Lymphoma
Interventions
DRUG:
PEG-rhG-CSF
Sponsor
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.